Bone Marrow for Joint Health

Research suggests that bone marrow and its derived cells — particularly bone marrow stem cells, bone marrow aspirate concentrate, and bone marrow stromal cells — show promise in supporting joint health across several contexts, including cartilage repair, meniscal regeneration, temporomandibular joint osteoarthritis, and hip conditions such as femoroacetabular impingement syndrome. The available evidence comes primarily from preclinical laboratory studies, animal models, and narrative reviews rather than large randomized controlled trials, with a small number of clinical reviews noting early but insufficient evidence for routine use of bone marrow concentrate injections in human patients. Studies indicate that bone marrow-derived stem cells can encourage cartilage cell growth, promote anti-inflammatory immune responses, and support tissue regeneration, including in experimental scaffold and transplantation models, though researchers consistently note that findings from cell cultures and animal studies will require validation in well-designed human clinical trials before firm conclusions can be drawn. The overall direction of the research is cautiously supportive, but the evidence base remains preliminary, and the field has not yet established standardized protocols or long-term safety and efficacy data for most bone marrow-based joint interventions.